ATORVASTATIN

Course overview

HMG-COA REDUCTASE INHIBITORS (STATINS) ARE LIPID-LOWERING MEDICATIONS USED IN THE PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE. THIS ACTIVITY REVIEWS THE INDICATIONS, CONTRAINDICATIONS, AND MECHANISM OF ACTION OF ATORVASTATIN FOR THE MANAGEMENT OF CORONARY HEART DISEASE AND FAMILIAL DYSLIPIDEMIAS, COVERING THE INDICATIONS, CONTRAINDICATIONS, ACTIVITY, ADVERSE EVENTS, AND OTHER KEY ELEMENTS OF ATORVASTATIN THERAPY. THIS ACTIVITY ALSO HIGHLIGHTS THE CRITICAL ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH CLINICALLY SIGNIFICANT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR INDIVIDUALS WITH RISK FACTORS FOR HEART DISEASE WHO CAN BENEFIT FROM STATIN THERAPY.